Skip to main content
. 2023 Nov 25;2:100849. doi: 10.1016/j.gimo.2023.100849

Table 2.

Population based testing of breast cancer by age and family history

Age (yrs) Number % All BC BRCA1 BRCA2 BRCA1/BRCA2 % PALB2 Any PV % Any PV
<40 70 6.6% 5 2 7 10.0% 2 9 12.9%
FH+ 11 2 1 3 27.3% 0 3 27.3%
FH- 59 3 1 4 6.8% 2 6 10.2%
40-49 186 17.5% 3 7 10 5.4% 3 13 6.9%
FH+ 43 2 1 3 7.0% 0 3 7.0%
FH- 143 1 6 7 4.9% 3 10 7.0%
50-59 396 37.6% 1 7 8 2.0% 4 12 3.0%
FH+ 90 0 4 4 4.4% 3 7 7.8%
FH- 306 1 3 4 1.3% 1 5 1.6%
60-69 315 29.8% 0 2 2 0.6% 0 2 0.6%
FH+ 67 0 1 1 1.5% 0 1 1.5%
FH- 248 0 1 1 0.40% 0 1 0.4%
70+ 96 9.0% 0 0 0 0.00% 0 0 0.0%
FH+ 28
FH- 66
Total FH+ 239 22.5% 4 7 11 4.6% 3 14 5.8%
Total FH+ 822 77.5% 5 11 16 1.9% 6 22 2.7%
Mean age 56.74
Median age 56.89
IQR 50.48-64.43

BC, breast cancer; FH+, first degree family history of BC; PV, pathogenic variant.